What is the global cancer tissue diagnostics market in 2026?

The global cancer tissue diagnostics market is projected to be valued at US$ 8.6 Bn in 2026.

What drives the global cancer tissue diagnostics market?

The market is driven by the rapidly rising global incidence of cancer, advancements in diagnostic technologies (IHC, ISH, molecular profiling, AI/digital pathology), and increasing adoption of precision medicine and early detection programs.

What is the growth rate for the global cancer tissue diagnostics market?

The global cancer tissue diagnostics market is poised to witness a CAGR of 5.5% between 2026 and 2033.

What are the key market opportunities in the global cancer tissue diagnostics market?

Key opportunities include expansion of digital pathology and AI-integrated diagnostics, growing adoption in emerging markets, and development of novel biomarkers and point-of-care tissue tests for personalized oncology.

Who are the key players in the global cancer tissue diagnostics market?

F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, and Becton, Dickinson and Company (BD) are some of the key players in the cancer tissue diagnostics market.

Table of Content - Cancer Tissue Diagnostics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Executive Summary
1. Global Cancer Tissue Diagnostics Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Recent Product Launches
3. Regulatory Landscape
4. Value Chain Analysis
5. Key Deals and Mergers
6. PESTLE Analysis
7. Porter’s Five Force Analysis
Price Trend Analysis, 2020 - 2033
1. Key Highlights
2. Key Factors Impacting Product Prices
3. Pricing Analysis, By Product Type
4. Regional Prices and Product Preferences
Global Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
3. Global Cancer Tissue Diagnostics Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis and Volume (Units) Analysis, By Product, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
    1. In Situ Hybridization (ISH) Test Kits
      1. Fluorescent In Situ Hybridization (FISH) Kits
      2. Chromogenic In Situ Hybridization (CISH) Kits
    2. Molecular Diagnostics Test Kits
      1. Polymerase Chain Reaction (PCR) Kits
      2. Next-generation Sequencing (NGS) Kits
    3. Companion Diagnostics Test Kits
      1. Genetic Testing Kits
      2. Biomarker Testing Kits
    4. Immunohistochemistry (IHC) Test Kits
  4. Market Attractiveness Analysis: By Product
4. Global Cancer Tissue Diagnostics Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
    5. Ovarian Cancer
    6. Hematologic Cancer
    7. Liver Cancer
    8. Pancreatic Cancer
    9. Skin Cancer (Melanoma)
    10. Others
  4. Market Attractiveness Analysis: By Application
5. Global Cancer Tissue Diagnostics Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
    1. Hospitals
    2. Specialty Clinics
    3. Long-term Care Centers
    4. Diagnostic Centers
    5. Academic & Research Institutes
  4. Market Attractiveness Analysis: End User
Global Cancer Tissue Diagnostics Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
7. Market Attractiveness Analysis
Europe Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
  6. Others
7. Market Attractiveness Analysis
East Asia Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
  6. Others
7. Market Attractiveness Analysis
South Asia & Oceania Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
7. Market Attractiveness Analysis
Latin America Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
7. Market Attractiveness Analysis
Middle East & Africa Cancer Tissue Diagnostics Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Product
  3. By Application
  4. By End User
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
  1. In Situ Hybridization (ISH) Test Kits
    1. Fluorescent In Situ Hybridization (FISH) Kits
    2. Chromogenic In Situ Hybridization (CISH) Kits
  2. Molecular Diagnostics Test Kits
    1. Polymerase Chain Reaction (PCR) Kits
    2. Next-generation Sequencing (NGS) Kits
  3. Companion Diagnostics Test Kits
    1. Genetic Testing Kits
    2. Biomarker Testing Kits
  4. Immunohistochemistry (IHC) Test Kits
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Ovarian Cancer
  6. Hematologic Cancer
  7. Liver Cancer
  8. Pancreatic Cancer
  9. Skin Cancer (Melanoma)
  10. Others
6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
  1. Hospitals
  2. Specialty Clinics
  3. Long-term Care Centers
  4. Diagnostic Centers
  5. Academic & Research Institutes
  6. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
2. Company Profiles (Details - Overview, Recent Developments)
  1. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Segments and Product & End User
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Danaher Corporation
  3. Agilent Technologies, Inc.
  4. Thermo Fisher Scientific Inc.
  5. Abbott Laboratories
  6. Becton, Dickinson and Company
  7. Merck KGaA
  8. QIAGEN N.V.
  9. Illumina, Inc.
  10. Bio-Rad Laboratories, Inc.
  11. Sakura Finetek Japan Co., Ltd.
  12. Quest Diagnostics Incorporated
  13. BioGenex Laboratories, Inc.
  14. Bio SB, Inc.
  15. Enzo Life Sciences, Inc.
  16. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Cancer Tissue Diagnostics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Quick Links

Our Partners

Secure Payments Through